Publication Details

EULAR points to consider for conducting clinical trials in systemic lupus erythematosus.

Gordon C, Bertsias G, Ioannidis JP, Boletis J, Bombardieri S, Cervera R, Dostál C, Font J, Gilboe IM, Houssiau F, Huizinga TW, Isenberg D, Kallenberg CG, Khamashta MA, Piette JC, Schneider M, Smolen JS, Sturfelt G, Tincani A, Van Vollenhoven R, Boumpas DT. Ann Rheum Dis. 2009; 68 (4): 470-6

Systemic lupus erythematosus (SLE) is a complex multi-organ disease, characterised by relapses and remissions.

PubMedID: 18388158